CHR Stock Price Chart
Daily OHLCV with technical indicators — pan, zoom, and customize your view
04
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits3
Ex-date
Split
Type
April 7, 2026
1-for-3
Reverse
Dec. 23, 2025
1-for-50
Reverse
Nov. 27, 2023
1-for-10
Reverse
10-Year Performance
Revenue, net income, margins and EPS trends
06
Revenue$149M2019-12-31 → 2025-12-31
EPS$24.072019-12-31 → 2025-12-31
Free Cash Flow·2023-12-31 → 2024-12-31
Net margin17.2%2020-12-31 → 2025-12-31
Valuation & Ratios07–12
Valuation
P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
CHR
5Y avg
Peer Median
Verdict
P/E
0.15Y avg ≈1.2
≈1.2
·
·
P/B (MRQ)
1.35Y avg ≈3.6
≈3.6
·
·
Price / Tangible Book (MRQ)
1.75Y avg ≈4.1
≈4.1
·
·
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability
Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
CHR
5Y avg
Peer Median
Verdict
Operating Margin
17.7%5Y avg ≈19.0%
≈19.0%
-0.05%
Top tier
EBITDA Margin
22.3%5Y avg ≈21.5%
≈21.5%
0.65%
Top tier
Pretax Margin
17.3%5Y avg ≈19.2%
≈19.2%
3.1%
Top tier
Net Profit Margin
17.2%5Y avg ≈19.0%
≈19.0%
2.5%
Top tier
ROA
6.9%5Y avg ≈12.0%
≈12.0%
2.0%
Top tier
ROE
7.6%5Y avg ≈14.6%
≈14.6%
4.7%
Top tier
ROIC
7.0%5Y avg ≈12.7%
≈12.7%
0.23%
Top tier
Financial Health
Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
CHR
5Y avg
Peer Median
Verdict
Debt / Equity
0.0
·
·
·
Current Ratio (MRQ)
3.35Y avg ≈7.2
≈7.2
1.9
Strong liquidity
Quick Ratio
10.15Y avg ≈4.7
≈4.7
1.4
Strong liquidity
Growth
Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Per Share Metrics
EPS, book value per share, cash flow per share, dividend per share
Metric
5Y trend
CHR
5Y avg
Peer Median
Verdict
EPS (Diluted)
$24.075Y avg ≈$61.89
≈$61.89
·
·
Revenue / Share
$139.835Y avg ≈$35.27
≈$35.27
·
·
Cash Flow / Share
$16.855Y avg ≈$4.96
≈$4.96
·
·
Capital Efficiency
Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
CHR
5Y avg
Peer Median
Verdict
Asset Turnover
0.45Y avg ≈0.6
≈0.6
0.5
Weak
Receivables Turnover
1.95Y avg ≈1.9
≈1.9
2.3
Weak
Revenue / Employee
≈$1.3M
·
·
·
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals
All metrics by year — income statement, balance sheet, cash flow
15
Income Statement16
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
Revenue
$149M
$147M
$152M
$157M
$153M
$124M
$66M
Cost of Revenue
$43M
$39M
$40M
$41M
$35M
·
·
R&D Expense
$5M
$3M
$2M
$1M
$920.0K
$691.0K
$749.0K
SG&A Expense
$5M
$3M
$6M
$6M
$3M
$10M
$3M
Operating Expenses
$123M
$122M
$123M
$130M
$117M
$93M
$39M
Operating Income
$26M
$26M
$29M
$27M
$36M
$31M
$27M
Interest Expense
·
·
·
$93.0K
$513.0K
$282.0K
$295.0K
Other Non-op
$-663.0K
$80.0K
$1M
$282.0K
$-255.0K
$531.0K
$50.0K
Pretax Income
$26M
$26M
$31M
$27M
$36M
$51M
$27M
Income Tax
$73.0K
$-34.0K
$61.0K
$413.0K
$976.0K
$2M
$191.0K
Net Income
$26M
$26M
$30M
$27M
$35M
$49M
$26M
EPS (Basic)
$24.07
$125.72
$150.31
$3.95
$5.40
$0.91
$0.64
EPS (Diluted)
$24.07
$125.72
$150.31
$3.95
$5.40
$0.83
$0.57
Shares (Basic)
1,064,433
206,544
172,750
6,812,387
6,538,118
53,844,237
41,204,025
Shares (Diluted)
1,064,433
206,544
172,750
6,812,387
6,538,118
59,126,237
46,484,025
EBITDA
$33M
$29M
$33M
$30M
$38M
$34M
$-2M
Balance Sheet26
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
Cash & Equivalents
$242M
$198M
$195M
·
·
$18M
$7M
Short-term Investments
·
·
·
·
·
$2M
·
Receivables
$80M
$77M
$81M
$98M
$63M
$81M
$51M
Prepaid Expense
$45M
$31M
$31M
$15M
$35M
$23M
$2M
Other Current Assets
·
·
·
$15M
$13M
$3M
$2M
Current Assets
$367M
$306M
$307M
$184M
$154M
$103M
$60M
PP&E (Net)
$17.0K
$33.0K
$85.0K
$160.0K
$242.0K
$251.0K
$331.0K
PP&E (Gross)
$829.0K
$1M
$1M
$1M
$1M
$1M
$911.0K
Accum. Depreciation
$812.0K
$979.0K
$987.0K
$956.0K
$831.0K
$757.0K
$580.0K
Intangibles
$35M
$41M
$20M
$20M
$17M
$16M
$15M
Other Non-current Assets
$77.0K
·
·
$1.0K
$21M
$21M
·
Total Assets
$402M
$347M
$328M
$206M
$195M
$143M
$80M
Accounts Payable
$3M
$2M
$10M
$6M
$13M
$8M
$5M
Short-term Debt
$8M
$13M
$5M
$6.1K
·
·
·
Current Liabilities
$32M
$40M
$46M
$33M
$35M
$35M
$16M
Capital Leases
$134.0K
$250.0K
·
$471.0K
$1M
$1M
$2M
Total Liabilities
$32M
$42M
$48M
$33M
$36M
$39M
$17M
Long-term Debt
·
·
$1M
·
·
·
·
Total Debt
$8M
$12.5K
·
·
·
·
·
Common Stock
·
·
$10.0K
$7.0K
$7.0K
$6.0K
$4.0K
Paid-in Capital
$138M
$113M
$106M
$27M
$26M
$9M
$13M
Retained Earnings
$233M
$207M
$181M
$151M
$124M
$89M
$50M
AOCI
$-2M
$-17M
$-9M
$-7M
$8M
$5M
$-2M
Stockholders' Equity
$370M
$305M
$280M
$172M
$159M
$104M
$62M
Liabilities + Equity
$402M
$347M
$328M
$206M
$195M
$143M
$80M
Shares Outstanding
·
·
10,070,012
6,812,440
68,122,402
5,788,635
41,204,025
Cash Flow13
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
D&A
$7M
$4M
$3M
$3M
$2M
$3M
$739.0K
Stock-based Comp
·
·
·
$391.0K
$181.0K
$2M
·
Deferred Tax
$73.0K
$-33.0K
$63.0K
$-53.0K
$713.0K
$-181.0K
$190.0K
Amort. of Intangibles
$7M
$4M
$3M
$3M
$2M
$3M
$532.0K
Other Non-cash
$-15M
$-7M
$8M
$-22M
$8M
$-48M
·
Operating Cash Flow
$18M
$23M
$42M
$8M
$46M
$9M
$26M
CapEx
·
$1.0K
$3.0K
$25.0K
$72.0K
·
·
Investing Cash Flow
$-709.0K
$-25M
$-3.0K
$-8M
$-1M
$-4M
$-15M
Stock Issued
·
·
$80M
·
$15M
·
·
Net Stock Activity
·
·
$80M
·
·
·
·
Financing Cash Flow
$18M
$11M
$82M
$508.0K
$13M
$5M
$-6M
Net Change in Cash
$44M
$3M
$124M
$-7M
$60M
$11M
$4M
Free Cash Flow
·
$23M
$42M
·
·
·
·
Profitability7
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
Operating Margin
17.7%
17.4%
19.2%
17.0%
23.7%
24.8%
·
Net Margin
17.2%
17.6%
20.0%
17.1%
23.1%
39.6%
·
Pretax Margin
17.3%
17.6%
20.1%
17.1%
23.7%
40.9%
·
EBITDA Margin
22.3%
20.0%
21.4%
18.9%
25.1%
27.1%
·
ROA
6.9%
7.7%
11.4%
13.4%
20.8%
43.9%
1.3%
ROE
7.6%
8.9%
13.5%
16.2%
26.9%
59.1%
65.6%
ROIC
7.0%
8.4%
10.4%
15.3%
22.2%
28.5%
·
Liquidity & Solvency4
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
Current Ratio
11.5
7.7
6.6
5.6
4.4
2.9
0.1
Quick Ratio
10.1
6.9
1.8
3.0
1.8
2.8
0.0
Debt / Equity
0.0
0.0
·
·
·
·
·
Interest Coverage
·
·
·
287.4
70.7
108.8
·
Efficiency2
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
Asset Turnover
0.4
0.4
0.6
0.8
0.9
1.1
·
Receivables Turnover
1.9
1.9
1.7
1.9
2.1
1.9
·
Per Share5
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
Book Value / Share
·
·
$27.80
$2.53
$2.33
$1.80
$0.70
Revenue / Share
$139.83
$14.25
$17.64
$2.31
$2.34
$2.09
·
Cash Flow / Share
$16.85
$2.21
$4.88
$0.11
$0.71
$0.15
·
Cash / Share
·
·
·
·
·
$0.31
$0.00
EPS (TTM)
$24.07
$125.72
$150.31
$3.95
$5.40
$0.83
·
Valuation (TTM)10
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
Revenue TTM
$149M
$147M
$152M
$157M
$153M
$124M
·
Net Income TTM
$26M
$26M
$30M
$27M
$35M
$49M
$3M
Market Cap
·
·
$32M
$995M
$804M
$1.59B
$729M
P/E
0.1
0.0
0.0
3.7
2.2
33.1
·
P/S
·
·
0.2
6.3
5.3
12.9
·
P/B
·
·
0.1
5.8
5.1
15.3
145.7
P / Tangible Book
·
·
0.1
6.5
5.7
18.0
·
P / Cash Flow
·
·
0.7
128.5
17.3
182.1
-423.0
P / FCF
·
·
0.7
·
·
·
·
Earnings Yield
1880.5%
5049.0%
4786.9%
27.1%
45.8%
3.0%
·
Income Statement15
Metric
Trend
Q4 2025
Q4 2023
Q4 2022
Q1 2020
Q4 2019
Q3 2019
Q2 2019
Q1 2019
Revenue
·
·
·
$10M
·
·
·
$14M
Cost of Revenue
·
·
·
$5M
·
·
·
$8M
R&D Expense
·
·
·
$206.0K
·
·
·
$197.0K
SG&A Expense
·
·
·
$1M
·
$0
$0
$639.0K
Operating Expenses
·
·
·
$7M
$-8M
$690.5K
$482.8K
$9M
Operating Income
·
·
·
$3M
$-6M
$-690.5K
$-482.8K
$4M
Other Non-op
·
·
·
$30.0K
$3M
$1M
$2M
$-5.0K
Pretax Income
·
·
·
$3M
·
·
·
$4M
Income Tax
·
·
·
$-5.0K
·
·
·
$172.0K
Net Income
·
·
·
$3M
$-3M
$552.3K
$1M
$4M
EPS (Basic)
·
·
·
$0.06
·
·
·
$0.10
EPS (Diluted)
·
·
·
$0.06
·
·
·
$0.09
Shares (Basic)
·
·
·
45,504,828
·
·
·
41,204,025
Shares (Diluted)
·
·
·
50,784,828
·
·
·
46,484,025
EBITDA
·
·
·
·
·
$-690.5K
$-482.8K
$-260.7K
Balance Sheet21
Metric
Trend
Q4 2025
Q4 2023
Q4 2022
Q1 2020
Q4 2019
Q3 2019
Q2 2019
Q1 2019
Cash & Equivalents
·
·
·
$10M
$34.5K
$47.3K
$141.1K
$126.3K
Receivables
·
·
·
$55M
·
·
·
·
Prepaid Expense
·
·
·
·
$47.3K
$75.6K
$112.3K
$152.0K
Other Current Assets
·
·
·
$3M
·
·
·
·
Current Assets
·
·
·
$68M
$81.8K
$122.9K
$253.4K
$278.3K
PP&E (Net)
·
·
·
$269.0K
·
·
·
·
PP&E (Gross)
·
·
·
$896.0K
·
·
·
·
Accum. Depreciation
·
·
·
$627.0K
·
·
·
·
Intangibles
·
·
·
$14M
·
·
·
·
Total Assets
·
·
·
$86M
$258M
$256M
$255M
$254M
Accounts Payable
·
·
·
$5M
$580.4K
$203.8K
$143.9K
$35.9K
Current Liabilities
·
·
·
$21M
$830.4K
$203.8K
$493.9K
$35.9K
Capital Leases
·
·
·
$1M
·
·
·
·
Total Liabilities
·
·
·
$23M
$2M
$1M
·
·
Common Stock
·
·
·
$5.0K
$711
$703
$696
$692
Paid-in Capital
·
·
·
$12M
$111.9K
$424.1K
$976.4K
$2M
Retained Earnings
·
·
·
$52M
$5M
$5M
$4M
$3M
AOCI
·
·
·
$-3M
·
·
·
·
Stockholders' Equity
·
·
·
$62M
$5M
$5M
$5M
$5M
Liabilities + Equity
·
·
·
$86M
$258M
$256M
$255M
$254M
Shares Outstanding
·
·
·
50,898,866
7,114,870
7,028,547
6,963,686
6,919,375
Cash Flow7
Metric
Trend
Q4 2025
Q4 2023
Q4 2022
Q1 2020
Q4 2019
Q3 2019
Q2 2019
Q1 2019
D&A
·
·
·
$448.0K
·
·
·
$61.0K
Stock-based Comp
·
·
·
$75.0K
·
·
·
·
Deferred Tax
·
·
·
$-73.0K
·
·
·
$172.0K
Operating Cash Flow
·
·
·
$-1M
$-512.7K
$-593.8K
$-335.3K
$3M
Investing Cash Flow
·
·
·
·
·
·
·
$-2M
Financing Cash Flow
·
·
·
$4M
$500.0K
$500.0K
$2M
$-2M
Net Change in Cash
·
·
·
$3M
$-12.7K
$-93.8K
$14.7K
$-1M
Profitability2
Metric
Trend
Q4 2025
Q4 2023
Q4 2022
Q1 2020
Q4 2019
Q3 2019
Q2 2019
Q1 2019
ROA
·
·
·
·
·
0.22%
0.91%
0.99%
ROE
·
·
·
·
·
11.1%
46.3%
50.3%
Liquidity & Solvency2
Metric
Trend
Q4 2025
Q4 2023
Q4 2022
Q1 2020
Q4 2019
Q3 2019
Q2 2019
Q1 2019
Current Ratio
·
·
·
·
·
0.6
0.5
7.7
Quick Ratio
·
·
·
·
·
0.2
0.3
3.5
Per Share3
Metric
Trend
Q4 2025
Q4 2023
Q4 2022
Q1 2020
Q4 2019
Q3 2019
Q2 2019
Q1 2019
Book Value / Share
·
·
·
·
·
$0.71
$0.72
$0.72
Cash / Share
·
·
·
·
·
$0.01
$0.02
$0.02
EPS (TTM)
$24.07
$150.31
$3.95
·
·
·
·
·
Valuation (TTM)7
Metric
Trend
Q4 2025
Q4 2023
Q4 2022
Q1 2020
Q4 2019
Q3 2019
Q2 2019
Q1 2019
Revenue TTM
$149M
$152M
$157M
·
·
·
·
·
Net Income TTM
$26M
$30M
$27M
$9M
·
$7M
$7M
$6M
Market Cap
·
·
·
·
·
$716M
$697M
$686M
P/E
0.1
0.0
3.7
·
·
·
·
·
P/B
·
·
·
·
·
143.1
139.4
137.1
P / Cash Flow
·
·
·
·
·
·
·
-2443.2
Earnings Yield
1880.5%
4786.9%
27.1%
·
·
·
·
·
Most recent period on the left · null values shown as ·
Financial Statements
Income statement, balance sheet, cash flow — annual, last 5 years
16
Metric
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Revenue
$149M
$147M
$152M
$157M
$153M
Operating Margin %
17.7%
17.4%
19.2%
17.0%
23.7%
Net Income
$26M
$26M
$30M
$27M
$35M
Diluted EPS
$24.07
$125.72
$150.31
$3.95
$5.40
Metric
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Debt / Equity
0.0
0.0
·
·
·
Current Ratio
11.5
7.7
6.6
5.6
4.4
Quick Ratio
10.1
6.9
1.8
3.0
1.8
Metric
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Free Cash Flow
·
$23M
$42M
·
·
Institutional owners (13F)
17
Institutional activity — Q1 2026 vs prior quarter
New positions
Exited positions
Increased
Decreased
Net shares change
1
5
1
0
·
Compared to Q4 2025. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair. Change vs prior quarter not shown: filer coverage differs too much between these two quarters for a reliable comparison.
Activists & 5%+ owners
8 positions
18
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders
7 insiders
· 4 officers · 5 directors